|
"""01-ENTERPRISE OPERATIONS MANAGER (PERPETUAL); VMTURBO, INC -- CATALOG : EOM-PE
|
316201500050W*2
|
$181,822
|
$181,822
|
N/A
|
"AFFIGENT, LLC"
|
|
"""01-GENOMATIXSUITEPE FULL, TO INCLUDE CHIPINSPECTOR, GENE REGULATION MODULE (MA
|
316201500063W*2
|
$280,276
|
$280,276
|
N/A
|
MARSHALL COMMUNICATIONS CORP.:
|
|
"""02-HP DESIGNJET T920 POSTSCRIPT EPRINTER - 36 LARGE-FORMAT PRINTER - COLOR - I
|
316201500039W*2
|
$19,817
|
$19,817
|
N/A
|
"KOI COMPUTERS, INC."
|
|
"""02-PUPPET ENTERPRISE VER. 3, (PREMIUM SUPPORT) 1 YEAR SUBSCRIPTION, PER NODE [
|
316201500036W*2
|
$175,920
|
$175,920
|
N/A
|
SYNERGY GROUP
|
|
"""07-STANDARD USER MAC LAPTOP; APPLE MACBOOK PRO 13 WITH RETINA DISPLAY; MAC OSX
|
263999900449I*3
|
$47,626
|
$47,626
|
N/A
|
DIGICON CORPORATION
|
|
"""BASE PERIOD (JUNE 1, 2015-NOVEMBER 30, 2015): LABOR NEGOTIATED NTE AMOUNT $1,4
|
27620150007B2610000
|
$1,431,388
|
$1,431,388
|
N/A
|
SAPIENT GOVERNMENT SRVS INC
|
|
"""BASE YEAR FOR ADMIN 3 SUPPORT FOR CBIIT - 1920 HOURS AT $39.91 PER HR. POP: AP
|
263201000015I*1
|
$76,627
|
$76,627
|
N/A
|
ADVANCED AUTOMATION TECHNOLOGI
|
|
"""BROAD INSTITUTE, INC.; HHSN261201400006C; CANCER GENOMICS CLOUD PILOTS; FY 15
|
261201400006C*2
|
$2,526,537
|
$2,526,537
|
N/A
|
"BROAD INSTITUTE, INC., THE"
|
|
"""CATALOG : 210-AAWL - STANDARD USER PC LAPTOP; DELL LATITUDE E7440; WINDOWS 7 P
|
263999900467I*3
|
$464,946
|
$464,946
|
N/A
|
PANAMERICA COMPUTERS INC
|
|
"""INSTITUTE FOR SYSTEMS BIOLOGY;HHSN261201400007C; CANCER GENOMICS CLOUD; OPTION
|
261201400007C*2
|
$2,363,129
|
$2,363,129
|
N/A
|
INSTITUTE FOR SYSTEMS BIOLOGY:
|
|
"""SEVEN BRIDGES GENOMICS, INC.; HHSN261201400008C; CANCER GENOMICS CLOUD PILOT;
|
261201400008C*3
|
$2,066,183
|
$2,066,183
|
N/A
|
SEVEN BRIDGES GENOMICS
|
|
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192990-02
|
$171,681
|
$171,681
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research
|
5P20CA192988-02
|
$190,237
|
$190,237
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
(NCI) Developing an Intermediate Energy Linac for Robotic Radiotherapy
|
1R43CA183390-01A1
|
$224,741
|
$224,741
|
BOUCHER, SALIME
|
RADIABEAM TECHNOLOGIES, LLC
|
|
(PDQ5)Integrated Genetic and Epigenetic Prognostication for Acute Myeloid Leukemi
|
5R21CA185365-02
|
$139,200
|
$139,200
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto
|
5R01CA190121-02
|
$332,000
|
$332,000
|
VERHAAK, ROELAND
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ3) AGEs and Race Specific Tumor Immune Response in Prostate Cancer
|
1R21CA194469-01
|
$140,445
|
$140,445
|
TURNER, DAVID
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
1R01CA194461-01
|
$443,669
|
$443,669
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQA-2) Reprogramming of circulating adipose stromal cells by mechanical stress
|
5R21CA184084-02
|
$160,643
|
$160,643
|
LI, RONG
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise
|
5R01CA179963-03
|
$525,787
|
$525,787
|
BRYAN, ANGELA
|
UNIVERSITY OF COLORADO
|
|
(PQA1) Molecular Mechanism of Metformin in Cancer
|
5R21CA184704-02
|
$228,375
|
$228,375
|
DAI, CHENGKAI
|
JACKSON LABORATORY
|
|
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer
|
5R01CA180277-03
|
$276,937
|
$276,937
|
LI, XIN
|
NEW YORK UNIVERSITY
|
|
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
|
5R01CA180033-03
|
$295,065
|
$295,065
|
MISKIMINS, W
|
SANFORD RESEARCH/USD
|
|
(PQA1)Toward understanding mechanisms of COX-2 driven metastasis of breast cancer
|
5R21CA185226-02
|
$169,061
|
$169,061
|
LYONS, TRACI
|
UNIVERSITY OF COLORADO DENVER
|
|
(PQA2) A NEW TOOL FOR CANCER PROGNOSTICATION BASED ON ALTERING VASCULAR HOMOEOSTA
|
1R21CA194634-01
|
$208,148
|
$208,148
|
SEN, ARINDAM
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
(PQA2) Elucidating the link between obesity, inflammation and estrogen signaling
|
5R21CA184611-02
|
$200,970
|
$200,970
|
STABILE, LAURA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
(PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival
|
5R01CA184953-02
|
$630,131
|
$630,131
|
CAAN, BETTE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
(PQA2) Impact of obesity on endogenous mutational hotspots
|
5R21CA185508-02
|
$168,019
|
$168,019
|
VASQUEZ, KAREN
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b
|
5R01CA185293-02
|
$329,248
|
$329,248
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
|
5R01CA180070-04
|
$339,116
|
$339,116
|
HEBER-KATZ, ELLEN
|
LANKENAU INSTITUTE FOR MEDICAL RESEARCH
|
|
(PQA2): Escape from breast tumor dormancy: convergence of obesity and menopause
|
5R01CA185530-02
|
$366,410
|
$366,410
|
MOSES, MARSHA
|
CHILDREN'S HOSPITAL CORPORATION
|
|
(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women
|
1R21CA194626-01
|
$227,288
|
$227,288
|
ORSULIC, SANDRA
|
CEDARS-SINAI MEDICAL CENTER
|
|
(PQA4) Detecting carcinogens in complex environments via energy transfer
|
5R21CA185435-02
|
$153,102
|
$153,102
|
LEVINE, MINDY
|
UNIVERSITY OF RHODE ISLAND
|
|
(PQA4) Molecularly Targeted Chemoprevention for Preneoplastic Squamous Epithelia
|
1R01CA194617-01
|
$474,319
|
$474,319
|
TSAI, KENNETH
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'
|
5R01CA179992-03
|
$175,891
|
$175,891
|
JONES, LEE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
(PQB-2) ""Driver"" vs. ""passenger"" epigenetic events in Ewing sarcoma
|
5R01CA183776-02
|
|
$0
|
LESSNICK, STEPHEN
|
UNIVERSITY OF UTAH
|
|
(PQB-3) Characterization of the immune response during mammary tumor initiation
|
5R21CA184541-02
|
$198,360
|
$198,360
|
SCHWERTFEGER, KATHRYN
|
UNIVERSITY OF MINNESOTA
|
|
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
|
5R01CA184926-02
|
$767,979
|
$767,979
|
JAFFEE, ELIZABETH
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQB2) Identification of Tumor-Derived Activators of Anti-Cancer Immune Responses
|
5R21CA190072-02
|
$180,843
|
$180,843
|
SUNWOO, JOHN
|
STANFORD UNIVERSITY
|
|
(PQB2) Ontogeny of the tumor-immune interplay in a developmental malignancy
|
5R21CA189990-02
|
$232,616
|
$232,616
|
MURRAY, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
|
5R01CA185062-02
|
$312,377
|
$312,377
|
FARRAR, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals
|
5R01CA185020-02
|
$325,181
|
$325,181
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
1R01CA194470-01
|
$464,569
|
$464,569
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQB5) Epigenetic Drivers of Hematopoietic Stem Cell Transformation
|
5R21CA184851-02
|
$195,963
|
$195,963
|
TROWBRIDGE, JENNIFER
|
JACKSON LABORATORY
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
5R01CA185486-02
|
$517,690
|
$517,690
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
5R01CA185137-02
|
$813,106
|
$813,106
|
CHAREST, ALAIN
|
TUFTS MEDICAL CENTER
|
|
(PQB6)Elucidating metastasis by real-time monitoring and tagging of CTCs in GEMMs
|
5R01CA184956-02
|
$611,094
|
$611,094
|
MANALIS, SCOTT
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
(PQC-1) Driver Events In IBD-Associated Neoplastic Progression
|
5R01CA190040-02
|
$613,138
|
$613,138
|
MELTZER, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQC1) PLK1 And EPHX3 Promotion Of Genomic Instability In Bronchial Dysplasia
|
5R21CA190124-02
|
$172,656
|
$172,656
|
MERRICK, DANIEL
|
UNIVERSITY OF COLORADO DENVER
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
1R01CA194596-01
|
$547,017
|
$547,017
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
Total relevant funding to Cancer for this search: $2,917,779,305
|